{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:36:50Z","timestamp":1792679810088,"version":"4.5.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,1]]},"DOI":"10.1210\/en.2010-0399","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T01:44:50Z","timestamp":1283391890000},"page":"4626-4634","source":"Crossref","is-referenced-by-count":78,"title":["Suppression of NF-\u03baB Increases Bone Formation and Ameliorates Osteopenia in Ovariectomized Mice"],"prefix":"10.1210","volume":"151","author":[{"given":"Neil","family":"Alles","sequence":"first","affiliation":[{"name":"Section of Pharmacology (N.A., N.S.S., J.H., M.K., H.S., K.A., K.O.), Department of Hard Tissue Engineering, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan"},{"name":"Department of Farm Animal Production & Health, Faculty of Veterinary Medicine & Animal Science (N.A.), University of Peradeniya, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niroshani S.","family":"Soysa","sequence":"additional","affiliation":[{"name":"Section of Pharmacology (N.A., N.S.S., J.H., M.K., H.S., K.A., K.O.), Department of Hard Tissue Engineering, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan"},{"name":"Division of Pharmacology, Faculty of Dental Sciences (N.S.S.), University of Peradeniya, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Section of Pharmacology (N.A., N.S.S., J.H., M.K., H.S., K.A., K.O.), Department of Hard Tissue Engineering, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masud","family":"Khan","sequence":"additional","affiliation":[{"name":"Section of Pharmacology (N.A., N.S.S., J.H., M.K., H.S., K.A., K.O.), Department of Hard Tissue Engineering, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Organic Biomaterials (A.S., K.A.), Institute of Biomaterials and Bioengineering, Graduate School, Tokyo Medical and Dental University, Tokyo 101-0062, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoyata","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Section of Pharmacology (N.A., N.S.S., J.H., M.K., H.S., K.A., K.O.), Department of Hard Tissue Engineering, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Ritzeler","sequence":"additional","affiliation":[{"name":"Aventis Pharma Deutschland (O.R.), 65929 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Akiyoshi","sequence":"additional","affiliation":[{"name":"Section of Pharmacology (N.A., N.S.S., J.H., M.K., H.S., K.A., K.O.), Department of Hard Tissue Engineering, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Aoki","sequence":"additional","affiliation":[{"name":"Organic Biomaterials (A.S., K.A.), Institute of Biomaterials and Bioengineering, Graduate School, Tokyo Medical and Dental University, Tokyo 101-0062, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ohya","sequence":"additional","affiliation":[{"name":"Section of Pharmacology (N.A., N.S.S., J.H., M.K., H.S., K.A., K.O.), Department of Hard Tissue Engineering, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"2019041121215063300_R1","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects.","volume":"115","author":"Raisz","year":"2005","journal-title":"J Clin Invest"},{"key":"2019041121215063300_R2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11914-008-0005-9","article-title":"Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window.","volume":"6","author":"Bilezikian","year":"2008","journal-title":"Curr Osteoporos Rep"},{"key":"2019041121215063300_R3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00024677-200605060-00003","article-title":"Anabolic agents for osteoporosis: what is their likely place in therapy?","volume":"5","author":"Girotra","year":"2006","journal-title":"Treat Endocrinol"},{"key":"2019041121215063300_R4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2008.10.146","article-title":"NF-\u03baB functions in osteoclasts.","volume":"378","author":"Soysa","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121215063300_R5","doi-asserted-by":"crossref","first-page":"37219","DOI":"10.1074\/jbc.C400258200","article-title":"The I\u03baB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.","volume":"279","author":"Dai","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041121215063300_R6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nm1054","article-title":"Selective inhibition of NF-\u03ba B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.","volume":"10","author":"Jimi","year":"2004","journal-title":"Nat Med"},{"key":"2019041121215063300_R7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm.1954","article-title":"Inhibition of osteoblastic bone formation by nuclear factor-\u03baB.","volume":"15","author":"Chang","year":"2009","journal-title":"Nat Med"},{"key":"2019041121215063300_R8","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1523\/JNEUROSCI.3118-03.2004","article-title":"Specific inhibition of I\u03baB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats.","volume":"24","author":"Tegeder","year":"2004","journal-title":"J Neurosci"},{"key":"2019041121215063300_R9","article-title":"inventors Indole or benzimidazole derivatives for modulating I\u03baB kinase","author":"Ritzeler","journal-title":"Germany patent WO2004\/022553 A1. 2004.03.18. Aventis Pharma Deutschland Gmbh"},{"key":"2019041121215063300_R10","article-title":"inventors Substitutes indoles for modulating NF-\u03baB activity","author":"Ritzeler","journal-title":"Germany patent WO 01\/30774 A1. 2001.03.03. Aventis Pharma Deutschland Gmbh"},{"key":"2019041121215063300_R11","article-title":"inventors Use of IkB kinase inhibitors for the treatment of pain","author":"Michaelis","journal-title":"Germany patent WO 2004\/022057 A1. 2004.03.18. Aventis Pharma Deutschland Gmbh"},{"key":"2019041121215063300_R12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00774-008-0026-6","article-title":"Inhibition of the classical NF-\u03baB pathway prevents osteoclast bone-resorbing activity.","volume":"27","author":"Soysa","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"2019041121215063300_R13","doi-asserted-by":"crossref","first-page":"E1011","DOI":"10.1152\/ajpendo.00534.2004","article-title":"The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis","volume":"288","author":"Gilbert","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121215063300_R14","first-page":"107","article-title":"Three-dimentional characterization of osteoclast bone-resorbing activity in the resorption lacunae.","volume":"56","author":"Soysa","year":"2009","journal-title":"J Med Dent Sci"},{"key":"2019041121215063300_R15","first-page":"35","article-title":"Three-dimensional measurements of bone resorption lacunae reveal inhibition of osteoclast activity by TNF-\u03b1 antagonists in vitro.","volume":"42","author":"Saito","year":"2006","journal-title":"Dentistry"},{"key":"2019041121215063300_R16","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1093\/nar\/29.4.e21","article-title":"Development of a sensitive multi-well colorimetric assay for active NF\u03baB","volume":"29","author":"Renard","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2019041121215063300_R17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S8756-3282(03)00054-1","article-title":"Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2.","volume":"32","author":"Hirata","year":"2003","journal-title":"Bone"},{"key":"2019041121215063300_R18","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI22513","article-title":"A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.","volume":"116","author":"Aoki","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041121215063300_R19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00774-007-0834-0","article-title":"Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in vivo.","volume":"26","author":"Hussain Mian","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"2019041121215063300_R20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2009.01.002","article-title":"Polysaccharide nanogel delivery of a TNF-\u03b1 and RANKL antagonist peptide allows systemic prevention of bone loss.","volume":"37","author":"Alles","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"2019041121215063300_R21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1359\/jbmr.091030","article-title":"The pivotal role of the alternative NF-\u03baB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.","volume":"25","author":"Soysa","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2019041121215063300_R22","first-page":"521","article-title":"Suppression of NF-\u03baB activation blocks osteoclastic bone resorption during estrogen deficiency.","volume":"21","author":"Strait","year":"2008","journal-title":"Int J Mol Med"},{"key":"2019041121215063300_R23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1359\/jbmr.070121","article-title":"Endogenous TNF\u03b1 lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-\u03baB.","volume":"22","author":"Li","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2019041121215063300_R24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yexcr.2005.09.016","article-title":"Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NF\u03baB.","volume":"312","author":"Eliseev","year":"2006","journal-title":"Exp Cell Res"},{"key":"2019041121215063300_R25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-291X(02)02141-1","article-title":"Malignant reversion of a human osteosarcoma cell line, Saos-2, by inhibition of NF\u03baB.","volume":"297","author":"Andela","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121215063300_R26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.21760","article-title":"Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor.","volume":"220","author":"Hayashi","year":"2009","journal-title":"J Cell Physiol"},{"key":"2019041121215063300_R27","doi-asserted-by":"crossref","first-page":"R427","DOI":"10.1186\/ar1692","article-title":"The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-\u03baB transcriptional activity in models of rheumatoid arthritis","volume":"7","author":"Keith Jr","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2019041121215063300_R28","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","article-title":"Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.","volume":"98","author":"Roggia","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121215063300_R29","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1074\/jbc.M106339200","article-title":"Expression of the osteoblast differentiation factor RUNX2 (Cbfa1\/AML3\/Pebp2\u03b1 A) is inhibited by tumor necrosis factor-\u03b1.","volume":"277","author":"Gilbert","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041121215063300_R30","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1074\/jbc.M507804200","article-title":"Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF \u03baB pathways.","volume":"281","author":"Lu","year":"2006","journal-title":"J Biol Chem"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/10\/4626\/9005079\/endo4626.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T01:54:48Z","timestamp":1711763688000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/151\/10\/4626\/2456184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,9,1]]},"published-print":{"date-parts":[[2010,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2010-0399","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,1]]}}}